Most Read News

Additionally, according to Cognizant, the litigation brought by former Wipro senior vice president (SVP) Muhammad Haque has been resolved with Wipro.

This approval is for the abbreviated new drug application (ANDA) of Bromfenac Ophthalmic Solution, 0.07%, which is used to treat postoperative inflammation and pain in patients undergoing cataract surgery.

Jatin Dalal expressed relief at resolving the matter, emphasizing his dedication to advancing Cognizant's growth objectives and delivering value to stakeholders.

Barclays joins UBS Group AG and Julius Baer Group Ltd. as companies expanding their wealth management operations in the area.

When comparing this floor pricing to Delhivery's closing price of ₹399.65 on July 9, a reduction of 0.7–3.5% is evident.

The IPO comprised a mix of fresh equity sale and an offer for sale (OFS).

Powell is set to speak before the House later in the day after his Senate hearing. CPI numbers for June are due on Thursday.

Listing Price: ₹356 on NSE (39.06% premium), ₹352 on BSE (37.52% premium)

Mankind Pharma's stock increased by more than 4% after the block deal. Mankind Pharma's shares were trading at ₹2,169 on the NSE at 09.23 am.

RVNL confirmed its status as the Lowest Bidder (L1) in a stock exchange filing, underscoring its commitment to enhancing railway infrastructure and capacity.